3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
4
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Sarcoma
12
Osteosarcoma
9
Rhabdomyosarcoma
7
Neuroblastoma
7
Wilms Tumor
6
Rhabdoid Tumor
6
Lymphoma, Non-Hodgkin
6
Hepatoblastoma
6
Sarcoma, Ewing
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Medulloblastoma
5
Histiocytosis, Langerhans-Cell
5
Glioma
5
Ependymoma
5
Central Nervous System Neoplasms
4
Liposarcoma
3
Carcinosarcoma
3
Sarcoma, Synovial
2
Ovarian Neoplasms
2
Neurofibrosarcoma
2
Melanoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Gliosarcoma
2
Glioblastoma
2
Endometrial Neoplasms
2
Desmoid Tumors
2
Carcinoma, Hepatocellular
2
Xanthogranuloma, Juvenile
1
Uterine Cervical Neoplasms
1
Interventions
pembrolizumab
11
Nivolumab
4
Erlotinib Hydrochloride
3
Docetaxel
3
Cetuximab
3
Capecitabine
3
tislelizumab
2
spartalizumab
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Immunoglobulin G
2
Gemcitabine
2
Filgrastim
2
Cyclophosphamide
2
tremelimumab
1
sargramostim
1
ribociclib
1
poly ICLC
1
pexidartinib
1
mirabegron
1
futibatinib
1
etoposide phosphate
1
entinostat
1
durvalumab
1
ciforadenant
1
cemiplimab
1
capivasertib
1
bempegaldesleukin
1
avelumab
1
X-Rays
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
X-Rays
×
Sarcoma
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled